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705 
THE FUTURE OF GMO LABELING: HOW A NEW 
FEDERAL LABELING SCHEME WILL ALTER 
PUBLIC DISCLOSURE 
INTRODUCTION 
Genetic modification is a process used for a myriad of purposes, 
including the cultivation of plant species that ultimately find their way into 
countless food products across the world. 1  As the usage of genetically 
modified organisms (GMOs) has grown, so has the public debate 
surrounding their presence in food, and, more specifically, their undisclosed 
presence in food. Until recently, the United States maintained next to no 
regulation on the labeling of GMO products.2 After many state legislatures 
began proposing and passing GMO-labeling laws, Congress passed one of 
its own.3 This Note will discuss the implications of the federal labeling 
scheme, and posits that although the scheme may disappoint grassroots anti-
GMO interests, the scheme will ultimately have the effect of providing 
consumers with the “right to know” what is in their food, and will reduce 
the presence of genetically modified (GM) foods in the marketplace. Part I 
provides background on GMOs and explains the regulatory role of the FDA. 
Part II discusses GMO-labeling legislation passed by certain states, a law 
recently passed by Congress, and the legal challenges faced by lawmakers 
when passing this type of legislation. Part III argues that the federal 
regulatory scheme is not a death knell for consumer autonomy, and that it 
will do little to weaken the fight against GMOs.  
I. BIRTH AND DEVELOPMENT OF GMO TECHNOLOGY 
Today, the words “genetically modified” tend to evoke divisiveness. Yet, 
the phenomenon of genetic manipulation existed long before the birth of 
genetic bioengineering just a few decades ago. Most students learn about 
Gregor Mendel in high school biology, the Augustinian monk who, in the 
mid-nineteenth century, conducted experiments by crossbreeding pea 
plants.4 Mendel’s studies were a systematic imitation of what farmers had 
done for centuries: combining the genes of different species of plants and 
animals to cultivate desirable traits.5 This type of genetic modification can 
                                                
1.  See discussion infra Part I.  
2.  See discussion infra Part II.  
3.  See discussion infra Part II.C.  
4.  Gregor Mendel: The Father of Modern Genetics, OFF. NIH HIST., https://perma.cc/Q9T2-
LY5H.  
5.  Id.  
Washington University Open Scholarship
 
 
 
 
 
 
706 WASHINGTON UNIVERSITY LAW REVIEW [VOL. 95:705 
 
 
 
occur naturally or through human intervention and is now unremarkable.6 
Many of the plants and animals bred today are the products of such passive 
or active manipulation. 7 
Centuries after Mendel pondered pea plant variations in his monastery 
garden, two American biochemists introduced recombinant-DNA (rDNA) 
technology, through which they isolated fragments of a gene from one 
bacterium and inserted it into another.8 The foreign DNA then replicated 
naturally, creating an entirely new type of bacterium.9 This discovery came 
at a pivotal time for a notable player in the genetic engineering game—
Monsanto. The company, which at the time was solely in the chemical 
manufacturing business, was feeling the effects of rising oil prices and 
public backlash against pesticides. 10  During the seventies, Monsanto 
stepped tentatively into the field, allocating a small amount of resources to 
genetic engineering research.11  
But a momentous event changed the company’s dallying approach. In 
1980, the Supreme Court held that man-made microorganisms are 
patentable subject matter.12 The decision helped to catalyze a biotechnology 
boom. Money surged into the industry, even funding companies who had 
yet to develop patentable organisms.13 Spurred by this breakneck growth, 
Monsanto devoted more resources to genetic engineering and the 
development of its own microorganisms.14 By 1990, Monsanto had invested 
over $800 million in biotech and had developed a number of products using 
genetic engineering.15 The attitude of industry insiders during this period 
was one of rapturous optimism and their testimonies conjured utopian 
prospects: bountiful crop yields untouched by chemicals and grown from 
                                                
6.  Michaeleen Doucleff, Natural GMO? Sweet Potato Genetically Modified 8,000 Years Ago, 
NPR (May 5, 2015), http://www.npr.org/sections/goatsandsoda/2015/05/05/404198552/natural-gmo-
sweet-potato-genetically-modified-8-000-years-ago. 
7.  Id.  
8.  Herbert W. Boyer & Stanley N. Cohen, CHEMICAL HERITAGE FOUND. (Aug. 11, 2015), 
https://perma.cc/5A87-JSMF. 
9.  Keith Schneider, Betting the Farm on Biotech, N.Y. TIMES MAG. (Aug. 10, 1990), 
http://www.nytimes.com/1990/06/10/magazine/betting-the-farm-on-biotech.html?pagewanted=all.  
10.  Id.  
11.  DANIEL CHARLES, LORDS OF THE HARVEST: BIOTECH, BIG MONEY, AND THE FUTURE OF 
FOOD 10 (2001).  
12.  Diamond v. Chakrabarty, 447 U.S. 303 (1980). The appellee, a microbiologist working for 
General Electric, sought a patent for a bacterium he had created through genetic manipulation. Id. at 
306. The newly-minted bacterium had the capability to break down crude oil, and suggested great 
potential as a mechanism for cleaning up oil spills. Charles, supra note 11, at 10–11. Chakrabarty created 
the bacterium in 1972 using methods which were long obsolete by the time his case was heard by the 
Supreme Court, but the holding applied broadly to human-made microorganisms and served as a boon 
to the field of genetic engineering and the companies invested in it. Id.  
13.  Charles, supra note 11, at 11.  
14.  Id.  
15.  Schneider, supra note 9.  
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soil devoid of fertilizers, which could grow as rapidly as the fabled 
beanstalk into a pristine atmosphere unmarred by pollution caused by the 
farm industry.16 All things seemed possible, a canonical idealism perhaps 
best epitomized by a remark made by the president of the International Plant 
Research Institute in 1981: “We are going to make pork chops grow on 
trees.”17  
Decades later, these lofty aspirations have yet to come to fruition. The 
facts and figures representing the relationship between GMOs and farm 
chemical use are disappointingly murky,18 but it is certainly safe to say that 
pesticides and herbicides are still widely used.19 Additionally, the agri-
business conglomerate is now faced with rancorous opposition from anti-
GMO activists, an effect probably not envisioned by those at the forefront 
of genetic engineering. A recent, extensive study corroborated the results of 
numerous others—all purport to find no health risks associated with 
GMOs.20 This evidence has not deterred anti-GMO groups. Some of their 
fervent propaganda—debunked falsehoods oozing paranoia—is easy to 
dismiss as pure conspiracy theory,21 while other arguments for labeling GM 
food come from less dubious sources.22 Regardless of the origin of anti-
GMO rhetoric, it often identifies Monsanto and other companies in its 
industry such as Bayer and DuPont as the root of GMO evil. To fight against 
big agri-business, anti-GMO groups push for legislation that would impose 
mandatory labeling requirements on companies.  
 
 
 
II. THE ROLE OF THE FDA, STATE AND FEDERAL LABELING LAWS, AND 
LEGAL HURDLES  
                                                
16.  See id.; Ann Crittenden, The Gene Machine Hits the Farm of Their New Usage, N.Y. TIMES 
MAG. (June 28, 1981), http://www.nytimes.com/1981/06/28/business/the-gene-machine-hits-the-farm-
of-their-new-usage.html?pagewanted=all.  
17.  Id.  
18.  Dan Charles, How GMOs Cut the Use of Pesticides—And Perhaps Boosted It Again, NPR 
(Sept. 1, 2016), https://perma.cc/X46Z-GNFS.  
19.  See Douglas Main, Glyphosate Now the Most-Used Agricultural Chemical Ever, 
NEWSWEEK (Feb. 2, 2016), https://perma.cc/9E4T-MHM4.  
20.  Elizabeth Weise, Academies of Science Finds GMOs Not Harmful to Human Health, USA 
TODAY (May 17, 2016), https://perma.cc/34ZS-NJPD; see also THE NAT’L ACADS. OF SCI., ENG’G & 
MED.: COMM. ON GENETICALLY ENGINEERED CROPS ET. AL., GENETICALLY ENGINEERED CROPS: 
EXPERIENCES AND PROSPECTS (2016).  
21.  See generally Stefaan Blanke, Why People Oppose GMOs Even Though Science Says They 
Are Safe, SCI. AM. (Aug. 18, 2015), https://perma.cc/UN6H-8P2U.  
22.  See, e.g., Jason Kelly, Opinion, I Run a G.M.O. Company—and I Support G.M.O. Labeling, 
N.Y. TIMES (May 16, 2016), https://www.nytimes.com/2016/05/16/opinion/i-run-a-gmo-company-and-
i-support-gmo-labeling.html?_r=0.  
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A.  The FDA’s Role in GMO Labeling 
The Food and Drug Administration (FDA) is the most obvious entity to 
assume responsibility for promulgating GMO-food labeling requirements. 
However, despite encouragement to do so, it has never issued anything more 
than nonbinding recommendations regarding the labeling of products 
containing GMOs. 23  The agency’s authority stems primarily from the 
Federal Food, Drug, and Cosmetic Act of 1938 (FDCA),24 which has been 
amended to augment the FDA’s ability to regulate what food producers may 
put in their products and how they must label them.25 Under the Food 
Additives Amendment of 1958, the FDA requires pre-approval before 
certain additives are included in food products.26 Additives exempt from the 
pre-approval requirement are those “generally recognized as safe” 
(GRAS).27 In 1990, Congress passed the National Labeling and Education 
Act (NLEA), which imposed mandatory, complete nutritional labeling, with 
the intent of allowing consumers to make better-educated decisions about 
the food they purchase.28 Shortly after the enactment of the NLEA, the FDA 
                                                
23.  Morgan Anderson Helme, Note, Genetically Modified Food Fight: The FDA Should Step 
Up to the Regulatory Plate So States Do Not Cross the Constitutional Line, 98 MINN. L. REV. 356, 363 
(2013).  
24.  Federal Food, Drug, and Cosmetic Act, Pub. L. No. 75-717, 52 Stat. 1040 (1938).  
25.  See Helme, supra note 23, at 360 (providing an overview of the evolution of the FDA from 
its enactment up to the present day). The Pure Food and Drug Act, enacted in 1906, was the first 
consumer protection law to give enforcement authority to the FDA, and was written with the goal of 
protecting consumers from “false and misleading” information. Pure Food and Drug Act, Pub. L. No. 
59-384, 34 Stat. 768 (1906); see also Fred H. Degnan, Biotechnology and the Food Label, in LABELING 
GENETICALLY MODIFIED FOOD: THE PHILOSOPHICAL AND LEGAL DEBATE 20 (Paul Weirich ed., 2007) 
[hereinafter LABELING GENETICALLY MODIFIED FOOD].  
26.  Federal Food, Drug, and Cosmetics Act, 21 U.S.C. § 321 (2012). The FDCA defines a “food 
additive” as:  
any substance the intended use of which results or may reasonably be expected to result, 
directly or indirectly, in its becoming a component or otherwise affecting the characteristics of 
any food . . . if such substance is not generally recognized, among experts qualified by scientific 
training and experience to evaluate its safety, as having been adequately shown through 
scientific procedures . . . to be safe under the conditions of its intended use.  
Id. 
27.  Currently, the GRAS distinction applies to 378 food additives, ranging from the familiar 
(beeswax, cornstarch, peanut oil, garlic), to the foreign (ferric pyrophosphate), to the sometimes 
alarming (ox bile extract, hydrochloric acid). See SCOGS (Select Committee on GRAS Substances), 
FDA, https://perma.cc/QWR8-CZPX. 
28.  See LABELING GENETICALLY MODIFIED FOOD, supra note 25, at 19.  
“[T]he mandatory nutrition labeling requirement of the NLEA was not designed to compel the 
disclosure of just routine information on food labels. Rather, the requirement was designed to 
require the disclosure of essential information that consumers need to choose foods wisely. To 
this end, consider that while NLEA specifies the nutrients for which information must be 
provided in nutrition labeling, the Act gives the FDA the authority to exclude any nutrient, 
regardless of its presumptive public health significance, from the declaration requirement when 
the agency finds that the information ‘is not necessary to assist consumers in maintaining 
healthy dietary practices.’ 
Id. 
https://openscholarship.wustl.edu/law_lawreview/vol95/iss3/4
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indicated that foods containing bioengineered ingredients would not be 
subject to the labeling requirements of the NLEA nor would GM ingredients 
be considered food additives so as to require pre-approval. This decision 
gave GM foods a “presumed GRAS status.”29 Even in the present age of 
GMO controversy, the FDA has not significantly shifted its views regarding 
disclosure of bioengineered ingredients. As long as the label is not 
misbranded by being false or misleading, it is acceptable to the FDA.30 This 
foundational principle—that product branding must be accurate and true—
extends to the labeling of GMOs.31 For instance, the FDA considers a label 
false and misleading if it purports that it is completely free of GMOs when 
it contains GM corn.32 The FDA provides guidance for producers who wish 
to voluntarily label their products as containing, or not containing, 
bioengineered ingredients.33 To ensure that a product is not misleading, the 
FDA gives numerous examples of wording that may be printed on food 
labels to express that the product was produced either with or without GM 
ingredients. 34  Some of these recommendations serve as clear 
pronouncements, while others are more convoluted.35 For example, a cereal 
company may label a product that contains no GM ingredients (Cereal A) 
                                                
29.  See Helme, supra note 23, at 362; see also Statement of Policy: Foods Derived from New 
Plant Varieties, FDA, 57 Fed. Reg. 22,984, 22,991 (May 29, 1992). The FDA presumed naturally 
occurring substances to be GRAS, as long as “the substance present in the food is one that is already 
present at generally comparable or greater levels in currently consumed foods.” Id. It equates this 
position to its rationale toward bioengineered ingredients—that they are different from their naturally 
occurring counterparts only through small variations in molecular structure, and therefore have GRAS 
status until there is evidence they are unsafe. Id.  
30.  See Jennifer L. Pomeranz, A Comprehensive Strategy to Overhaul FDA Authority for 
Misleading Food Labels, 39 AM. J. L. & MED. 617 (2013) for a comprehensive explanation of the 
prohibition on misbranding. The FDA considers a product to be misbranded if it has a false or misleading 
label, lacks proper identification, fails to disclose required information, or does not comply with 
requirements specified by the FDA. Id. at 620. Pomeranz asserts that the FDA approaches cases of 
alleged misbranding inconsistently and ineffectively, leading to confusion as to the permissibility of 
certain claims advertised by producers. Id. at 630.  
31.  Helme, supra note 23 at 362. “It is within this regulatory framework that the FDA considers 
the use in food of new plant varieties developed through genetic modification.” Id.  
32.  Guidance for Industry: Voluntary Labeling Indicating Whether Foods Have or Have Not 
Been Derived from Genetically Engineered Plants, FDA, https://perma.cc/P2DH-DPBJ [hereinafter 
FDA Guidance]. 
33.  Id. Although variations of the terms “genetically modified” and “bioengineered” are often 
used interchangeably, even on food labels, the FDA chooses to identify what are colloquially referred 
to as GMOs as “bioengineered” ingredients. Id. The rationale behind this choice is that “the term 
‘genetically modified’ can encompass any alteration to the genetic composition of a plant, including 
alterations achieved through traditional hybridization or breeding techniques,” therefore the term 
“genetically modified” “could apply to most cultivated food crops since most food crops are the product 
of selective breeding.” Id. Another reason for this preference is that the word “organism,” is represented 
by the letter O in “GMO.” Id. According to the FDA, “[m]ost foods do not contain entire organisms,” 
but are instead derived from genetically engineered organisms, which could potentially lead to 
confusion. Id.  
34.  Id.  
35.  See FDA Guidance, supra note 32 for a comprehensive list of labeling recommendations.  
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as “not genetically engineered,” and a product that contains GM soybeans, 
for instance, as “genetically engineered” (Cereal B).36 However, the FDA 
guidance also submits that Cereal A may be labeled with the words “[o]ur 
corn growers do not plant bioengineered seeds” and a statement on Cereal 
B may say “[s]ome of our growers plant soybean seeds that were developed 
through modern biotechnology to be drought tolerant.”37  In the case of 
Cereal A, does the label mean that although the corn is not genetically 
engineered, other ingredients are? The answer is unclear. The label on 
Cereal B uses the word “biotechnology,” but does not refer to genetic 
modification or bioengineering. The meaning of such a statement may 
puzzle to even the most discerning consumers. This issue is addressed by 
the FDA, which warns that even a truthful statement may be misleading.38 
For example, the guidance states—  
[O]n a product made largely of flour derived from genetically 
engineered corn and a small amount of non-genetically engineered 
soybean oil, a claim that the product ‘does not contain bioengineered 
soybean oil’ could be misleading if consumers believe that the entire 
product, or a larger portion of it than is actually the case, is free of 
bioengineered material. It may be necessary to carefully qualify the 
statement in order to ensure that consumers understand its 
significance.39 
This instruction still fails to address the potential circumstance in which 
a product’s primary ingredient is not bioengineered. If the hypothetical 
product in the FDA’s example was composed of mostly of non-genetically 
engineered soybean oil and only in small part of flour derived from 
genetically engineered corn, would it be misleading for the producer to label 
the product as not containing bioengineered soybean oil? The failure of the 
guidance to address such a situation implies that it would be acceptable and 
not considered misleading to consumers. However, it seems probable that a 
consumer who sees such a statement would assume it means that the product 
contains no GM ingredients.   
The FDCA does not provide a private right of action, and the FDA cannot 
impose monetary penalties for misleading food labels.40 Typically, the only 
consequence facing the companies responsible for misbranded products is 
receiving a Warning Letter from the FDA.41 Rarely do companies suffer 
                                                
36.  Id.  
37.  Id.  
38.  Id.  
39.  Id.  
40.  See Pomeranz, supra note 30, at 635.  
41.  Id. at 632. A Warning Letter requires the recipient to correct the misleading information on 
its labels. The currently misbranded product will not be taken off shelves, however, unless it is hazardous 
https://openscholarship.wustl.edu/law_lawreview/vol95/iss3/4
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sanctions for misleading label violations.42 The lack of binding regulation 
under the FDCA allowed for the passage of a federal GMO-labeling law. 
Although the federal law  applies to any food subject to the labeling 
requirements of the FDCA, it amended the Agricultural Marketing Act, and 
mandates the eventual creation of a labeling scheme that, once finalized, 
will  be promulgated by the US Department of Agriculture rather than the 
FDA. 43  The law therefore moves past the FDA’s nonbinding 
recommendations for GMO-labeling and imposes what appear to be 
mandatory disclosure requirements.44 
B. State Efforts to Enact GMO Labeling Laws 
In 2014, no federal laws regulated the labeling of GMOs.45 In response 
to growing concerns over the widespread use of GM ingredients and the 
challenges faced by consumers who wished to avoid it, Vermont put forth 
an act relating to the “labeling of food produced with genetic engineering.”46 
The Act, Act 120, which went into effect on July 1, 2016, was designed to 
“[r]educe and prevent consumer confusion and deception,” thereby 
allowing people to make “informed” decisions when purchasing food.47 It 
required that all food produced wholly or in part with GM ingredients be 
“clear[ly] and conspicuous[ly]” labeled.48 Furthermore, it prohibited those 
products from being touted as “natural.”49  
Vermont was not the first state to pass a law requiring the labeling of 
GM products. The Maine and Connecticut legislatures both succeeded in 
                                                
to health or would lead to injury due to its misleading label. The FDA may also obtain an injunction 
from the Department of Justice or file criminal charges against the company in question, but only in the 
most extreme cases. Id.  
42.  Id. at 633.  
The FDA has said that Warning Letters should be issued for violations ‘that may actually lead 
to an enforcement action’ if not corrected; however, this is not an accurate account of its 
enforcement activity. Rather, the Warning Letter represents the enforcement action for cases of 
mislabeled food products. There is no other viable enforcement action when a violation occurs 
and worse, not all violations actually garner a letter. 
Id. (citations omitted). 
43.  Act of July 29, 2016, Pub. L. No. 114-216, 130 Stat. 834, 834–39 (2016).  
44.  But see Stephanie Strom, G.M.O. Labeling Bill Clears First Hurdle in the Senate, N.Y. 
TIMES (July 6, 2016), https://www.nytimes.com/2016/07/07/business/gmo-labeling-bill-passes-first-
hurdle-in-senate.html. Wenonah Hauter, executive director of a prominent environmental advocacy 
group, claimed that “the industry wins what are essentially voluntary requirements under this G.M.O. 
labeling ‘compromise.’” Id.  
45.  Bonnie Smith & Laura Murphy, Vermont Act 120: A Light in the DARK for GMO Food 
Labeling, VT. J. ENVTL. L., https://perma.cc/8C25-UV4Y.  
46.  VT. STAT. ANN. tit. 9, § 3043 (2015).  
47.  VT. STAT. ANN. tit. 9, § 3041 (2015).  
48.  VT. STAT. ANN. tit. 9, § 3043 (2015).  
49.  Id.  
Washington University Open Scholarship
 
 
 
 
 
 
712 WASHINGTON UNIVERSITY LAW REVIEW [VOL. 95:705 
 
 
 
passing mandatory labeling laws, subject to certain conditions.50  GMO-
labeling initiatives have been proposed in most states, but the overwhelming 
majority of them never became law.51 At first this phenomenon appears 
paradoxical. If most Americans are in favor of mandatory GMO disclosure, 
then labeling bills should face minimal challenges in state legislatures or on 
ballot initiatives. Yet, the food industry fought hard against labeling 
legislation; companies and trade associations which stood to lose business 
and/or experience higher costs due to GMO labeling laws combatted 
labeling bills’ passage financially—spending millions of dollars in states 
that proposed any such legislation.52  
C. Recent Federal Legislation  
After the passage of Act 120, the Grocery Manufacturers’ Association, 
along with other food industry trade groups, challenged the law’s disclosure 
requirement on constitutional grounds in federal district court. 53  The 
complaint was dismissed in April 2015, 54  but the food industry was 
galvanized by the possibility of restrictive state labeling laws going into 
effect. In March of 2015, the Safe and Accurate Food Labeling Act was 
introduced in the Federal House of Representatives.55 Branded the “Deny 
Americans the Right to Know” or “DARK” Act by pro-labeling advocates, 
the bill was designed to impose only the most minimal requirements upon 
                                                
50.  See Julie M. Muller, Naturally Misleading: FDA’s Unwillingness to Define “Natural” and 
the Quest for GMO Transparency Through State Labeling Initiatives, 48 SUFFOLK U. L. REV. 511, 512 
(2015); Act of June 25, 2013, Pub. Act 13-183 (Conn. 2013) (Reg. Sess.) (codified at scattered sections 
of Conn. Gen. Stat. Ann. § 21a). Whether the Connecticut law would go into effect was conditioned on 
the passage of similar laws in at least four other states, including at least one that bordered Connecticut. 
Id. at § 3; Me. Rev. Stat. Ann. tit. 22, §§ 2591–2596 (titled the Act to Protect Maine Food Consumers' 
Right to Know about Genetically Engineered Food). The Maine law would not go into effect unless at 
least five other states or states with a combined population of 20 million people enacted similar laws. 
Id. at § 2.  
51.  Muller, supra note 50, at 512; see also Ross H. Pifer, Mandatory Labeling Laws: What Do 
Recent State Enactments Portend for the Future of GMOs? 118 PENN ST. L. REV. 789, 799–803. 
Proposition 37, a 2012 California referendum initiative which would have instated a mandatory GMO 
labeling standard in the state, was defeated by a “no” vote of 51.41%. Id. at 801. 
52.  Pifer, supra note 51, at 801.  
53.  Grocery Mfrs. Ass’n v. Sorrell, 102 F. Supp. 3d 583 (D. Vt. 2015).  
54.  Plaintiffs alleged that Act 120 should be invalidated because it violated the dormant 
Commerce Clause through the discriminatory effects it would have on interstate commerce. Id. at 605–
06. They argued that the burdens imposed by the Act would fall disproportionately on out-of-state food 
manufacturers, who would be forced to change their entire labeling scheme to comply with the law, 
potentially leading to conflicts with other states’ labeling laws. Id. at 608. The court was not swayed by 
this argument, explaining that the burden placed on out-of-state manufacturers was no greater than the 
burden on in-state manufacturers. Additonally, out-of-state manufacturers were free to charge higher 
prices on their products in Vermont to offset the costs of compliance. Id. The plaintiffs also challenged 
the law on preemption grounds, which the court likewise dismissed. Id.  
55.  Safe and Accurate Food Labeling Act of 2015, H.R. 1599, 114th Cong. (1st Sess. 2015). 
Republican representative Mike Pompeo of Kansas sponsored the bill. Id.  
https://openscholarship.wustl.edu/law_lawreview/vol95/iss3/4
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food companies and thwart states’ attempts to pass their own labeling 
laws.56 The bill passed the House, but died in the Senate.57 Initially, the 
bill’s failure appeared to be a triumph for pro-labeling advocates and states 
like Vermont that wished to pass mandatory labeling legislation. 58 
However, driven by the looming effective date of Vermont Act 120, 
senators reached a bipartisan compromise on GMO labeling legislation.59 
The deal passed the Senate as a rider on another Senate bill and was 
approved by the House and signed into law less than a month after the 
Vermont law’s effective date, pre-empting it and all other state GMO-
labeling legislation.60 The compromise received support from food trade 
associations.61 However, although it was touted as an adequate compromise 
for both sides of the aisle, most Democratic senators voted against it.62 
Opponents viewed the compromise bill as effectively the same as the 
original, but packaged differently.63 
On the surface, the most conspicuous difference between the original 
House bill and the compromise signed into law (hereinafter referred to as 
the Safe Act) is that the former allowed a voluntary labeling scheme, while 
the latter imposes mandatory labeling requirements on food producers.64 
Functionally, this distinction may not be important. The original House bill 
contained specifications for a GM food certification program.65 Companies 
would be free to choose whether to label their food as containing or not 
containing GM ingredients, and their products would have to meet a number 
of criteria in order to bear the label “GMO-free.”66 The bill specifically 
deferred to the FDA regarding the term “natural,” suggesting that foods 
containing GMOs could still bear the “natural” label. 67  According to 
                                                
56.  Id; Michal Addady, President Obama Signed This GMO Labeling Bill, FORTUNE (July 31, 
2016), https://perma.cc/3YMV-2BPS.  
57.  Stephanie Strom, Bill to Stop States Requiring Labeling of GMO Foods Fails, N.Y. TIMES 
(Mar. 16, 2016), https://www.nytimes.com/2016/03/17/business/bill-to-stop-states-requiring-labeling-
of-gmo-foods-fails.html?_r=0.  
58.  Id. Senator Bernie Sanders described the vote as a “victory for the American people over 
corporate interests.” Id.  
59.  Helena Bottemiller Evich, GMO Labeling Deal ‘Close’, POLITICO (June 21, 2016, 10:00 
AM), https://perma.cc/4KNC-XMWC. Democratic Senator Debbie Stabenow and Republican Pat 
Roberts drafted the GMO compromise. Id.  
60.  Act of July 29, 2016, Pub. L. No. 114-216, 130 Stat. 834, 834–39 (2016). 
61.  Erik Wasson, Senate GMO Labeling Deal Would Ban State Requirements, BOSTON GLOBE 
(June 25, 2016), https://www.bostonglobe.com/business/2016/06/24/senate-gmo-labeling-deal-would-
ban-state-requirements/4XwcVSUMK8uMK98oQENGXI/story.html.  
62.  U.S. Senate Roll Call Votes—Vote 123 on the Motion to Concur in the House Amendment to 
S.764 with Further Amendment, 114th Cong. (2nd Sess. 2016), https://perma.cc/SPW4-L2DK. 
63.  See supra note 44 and accompanying text.  
64.  Safe and Accurate Food Labeling Act of 2015, H.R. 1599, 114th Cong. (1st Sess. 2015); 
130 Stat. at 834–39.  
65.  Id.  
66.  Id.  
67.  Id.   
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lawmakers in support of the bill, this federal scheme was passed in an effort 
to prevent states from enacting their own laws, which would make it 
challenging and expensive for food companies to satisfy the requirements 
of a “patchwork” of varying state laws. 68  Yet an examination of the 
conditions precedent for effectuation in state GMO labeling laws indicate 
that complying with a differentiated variety of state laws would probably 
not emerge as an issue, contrary to the outcry from big-food interests. 69  
Essentially, the House bill was designed to barely change the status quo, 
serving only as a mechanism to preempt the state labeling laws that did 
exist.70  
Conversely, the Safe Act requires the establishment of “a national 
mandatory bioengineered food disclosure standard.”71 The law tasks the 
Secretary of Agriculture with formulating and instituting the standard 
within two years, subject to certain specifications.72 Although requirements 
are markedly less lenient on food companies than in the original bill, it is 
evident why food companies and trade associations are satisfied with the 
law, while pro-labeling advocates are staunchly against it.73 It ostensibly 
creates a mandatory labeling requirement, yet is subject to many significant 
exceptions that will allow companies to avoid labeling food containing GM 
ingredients.74 For example, foods that are derived from animals cannot be 
considered bioengineered “solely because the animal consumed feed 
produced from, containing, or consisting of a bioengineered substance.”75 
The USDA will determine the threshold amount of GM ingredients 
necessary in order to require that the food be labeled as genetically 
engineered and establish the request process by which the agency will 
determine whether a food must be labeled.76 These provisions spark concern 
that the USDA will be too lenient in deciding on allowable thresholds and 
other necessary requirements that companies must meet to avoid a GMO 
label.77  
One of the most decried provisions of the law states that a label’s 
disclosure statement may be in the form of “text, symbol, or electronic or 
                                                
68.  Puneet Kollipara, Opposition Stalls U.S. Senate Bill Aimed at Blocking GMO Food Labels, 
SCI. MAG. (Mar. 17, 2016, 11:45 AM), https://perma.cc/7R96-HJNP.  
69.  See supra note 50 and accompanying text.  
70.  Kollipara, supra note 68.  
71.  Act of July 29, 2016, Pub. L. No. 114-216, 130 Stat. 834, 834–39 (2016) [hereinafter the 
Safe Act]. 
72.  Id.  
73.  Jean Halloran, Consumers Union Letter to US Senate in Opposition of S.764 to Preempt 
State GMO Labeling Laws, CONSUMERS UNION (July 1, 2016), https://perma.cc/9XK6-GB6V.  
74.  Id.  
75.  Safe Act, supra note 71.  
76.  Id.  
77.  Halloran, supra note 73.  
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digital link . . . with the disclosure option to be selected by the food 
manufacturer.”78 This proves worrisome to disclosure supporters, who see 
the digital link option (also known as a quick-response, or QR, code) to be 
exclusionary; consumers without smartphones will be unable to scan the 
codes at all, and most smartphone owners will not take the time to scan 
every item they put in their carts.79 Furthermore, since QR codes are already 
in use and appear on many food labels, the mere presence of a QR code is 
not a “de facto indication that a product contains GMOs.” 80  Allowing 
disclosures through QR code thereby does not permit the consumer to 
determine whether a product does or does not contain GMOs through a brief 
inspection of its label.81   
Lawmakers typically rely on one of two justifications when they require 
mandatory labeling on any product, food or otherwise. First, there is a risk 
when consuming or using a product that may lead to harm.82 If a product is 
associated with proven harms, risk-based thinking can form the basis for 
mandatory labeling even when a risk has not yet been established, but may 
be proven in the future.83 This so-called “precautionary principle” is the 
rationale of many pro-labeling advocates, who believe that although there 
are no known risks associated with consumption of GM foods, they have 
not been widely consumed for a long enough period of time to properly and 
accurately determine the effect they may have on humans. 84  The 
precautionary attitude prevails in many legislative systems, which is why 
other countries have succeeded in enacting relatively restrictive labeling 
schemes or imposing outright bans on GM products.85  
Second, if the people want it, they should be able to have it.86 This 
autonomy-based justification gives no regard to the rationale behind the 
majority’s demand for a federal GMO labeling scheme, therefore rendering 
the grounds for an autonomy-based justification “boundaryless.” 87 
Elemental to the consumer autonomy principle is the notion of the 
consumers’ “right to know.”88 The right to know is an accepted pretext for 
the passage of labeling requirements in other countries, but such 
                                                
78.  Safe Act, supra note 71.  
79.  Halloran, supra note 73; Greg Trotter, Will Food Shoppers Really Seek Out GMO 
Information Using QR Codes?, CHI. TRIB. (July 12, 2016, 1:44 PM), http://www.chicagotribune.co 
m/business/ct-gmo-labeling-qr-codes-0713-biz-20160712-story.html.  
80.  Halloran, supra note 73.  
81.  Trotter, supra note 79.  
82.  Philip G. Peters & Thomas A. Lambert, Regulatory Barriers to Consumer Information About 
Genetically Modified Foods, in LABELING GENETICALLY MODIFIED FOOD 153, supra note 25.  
83.  Id.  
84.  Id.  
85.  Id.  
86.  Id. at 155.  
87.  Id. at 154.  
88.  Id.  
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requirements in the United States can seemingly only be established with 
the backing of established health and safety concerns.89  
Proposed GMO labeling laws have not consistently represented either a 
risk-based or autonomy-based justification, but have borrowed pieces from 
each philosophy. The original act contemplated by Vermont, for example, 
explicated the need for legislation because “[g]enetically engineered foods 
potentially pose risks to health, safety, agriculture, and the environment,” 
and that “[f]or multiple health, personal, religious, and environmental 
reasons . . . food produced from genetic engineering should be labeled as 
such.”90 The authors of the original bill continued to justify its necessity by 
stating that “[p]ublic opinion polls . . . indicate that a large majority of 
Vermonters want foods produced with genetic engineering to be labeled as 
such.” 91  Through this justification, the Vermont legislature evoked the 
precautionary principle as the driving force behind its citizens’ desire to 
know if products are produced with genetic engineering, therefore justifying 
the law by both the potential risk posed by GMOs and consumer autonomy 
principle. 
The absence of evidence showing that GMOs are harmful is significant 
when faced with the question of government interest in passing labeling 
laws. Consumption has not been shown to have any detrimental impact on 
human health, and, so far, anti-GMO activists have not presented any 
compelling data showing the benefits of avoiding GMOs. 92  As one 
columnist put it: “‘GMO-free’ does not mean fair trade, and it does not mean 
sustainable, and it does not mean monoculture-averting, and it does not 
mean rainforest-enabling, and it does not mean labor-friendly, and it does 
not mean healthy . . . .”93  
The Monsanto company is the preeminent evil for anti-GMO advocates. 
For certain consumer groups, it represents the nefarious machine of 
corporate control, infiltrating worldwide agriculture and contaminating the 
                                                
89.  Neil D. Hamilton, Legal Issues Shaping Society’s Acceptance of Biotechnology and 
Genetically Modified Organisms, 6 DRAKE J. AGRIC. L. 81, 96 (2001).  
90.  H.R. 112, 2014 Leg., 2013–2014 Sess. (Vt. 2014).  
91.  Id. at § 1(5)(A). 
92.  See, e.g., Niraj Chokshi, Stop Bashing G.M.O. Foods, More Than 100 Nobel Laureates Say, 
N.Y. TIMES (June 30, 2016), https://www.nytimes.com/2016/07/01/us/stop-bashing-gmo-foods-more-
than-100-nobel-laureates-say.html. Dozens of physicists, chemists, and doctors of medicine contributed 
to a letter written to Greenpeace, stating that  
[s]cientific and regulatory agencies around the world have repeatedly and consistently found 
crops and foods improved through biotechnology to be as safe as, if not safer than those derived 
from any other method of production . . . [t]here has never been a single confirmed case of a 
negative health outcome for humans or animals from their consumption. 
Id.  
93.  James Hamblin, No One is Denying A ‘Right to Know What’s in My Food,’ ATLANTIC (July 
24, 2015), https://perma.cc/NEB5-Y2VL.  
https://openscholarship.wustl.edu/law_lawreview/vol95/iss3/4
 
 
 
 
 
 
2017] THE FUTURE OF GMO LABELING 717 
 
 
 
food supply.94 However, most of these advocate groups focus singularly on 
the alleged health effects of GM ingredients, even though they have been 
proven unfounded many times over. 95  Consequently, the right to know 
based on the potential health effects caused by GMO consumption is the 
driving factor behind the demand for informative labeling laws.96 
There are, however, other legitimate reasons beyond alleged detrimental 
health effects that consumers can point to as justification for avoiding 
GMOs, especially if their opposition is primarily against corporate control 
of the American agricultural system. Most of the GM crops grown in the 
United States are designed to resist insects, and even more are engineered 
to withstand chemicals which kill weeds.97 Not surprisingly, pesticide use 
has diminished since the advent of pest-resistant crops, but the use of 
herbicides has risen drastically.98 Because their engineered crops will not be 
harmed by herbicide use, farmers liberally utilize the chemicals to kill off 
weeds.99  This excessive application has caused many weeds to develop 
resistance to the chemicals, creating the demand for new formulations of 
herbicide and, of course, GM crops that can resist them.100 Roundup is the 
most widely used herbicide, with about 1.4 billion pounds of it applied to 
crops worldwide each year. 101  It is manufactured by Monsanto. 102  The 
active ingredient in Roundup, glyphosate, has a “low toxicity for humans” 
according to the EPA,103 but the International Agency for Research on 
Cancer (a subsection of the World Health Organization) has classified 
glyphosate as a substance that is “probably carcinogenic to humans.”104 
                                                
94.  See Millions Against Monsanto, ORGANIC CONSUMERS ASS’N, https://www.organiccon 
sumers.org/campaigns/millions-against-monsanto (last visited Aug. 23, 2017). 
95.  See William Saletan, Unhealthy Fixation, SLATE (July 15, 2015, 5:45 AM), https://perma.c 
c/Z657-LB6M.  
96.  See, e.g., Why Label?, JUSTLABELIT, https://perma.cc/4RJL-WE6A (last visited Aug. 28, 
2017) (“While our reasons for wanting to know what’s in our food may vary, what unifies us is the belief 
that it’s our right.”).  
97.  Saletan, supra note 95. About three-quarters of corn and soybeans are genetically engineered 
to resist insects, and eighty to eighty-five percent of the same crops are engineered to resist herbicides. 
Id. 
98.  Danny Hakim, Doubts About the Promised Bounty of Genetically Modified Crops, N.Y. 
TIMES (Oct. 29, 2016), https://www.nytimes.com/2016/10/30/business/gmo-promise-falls-short.html 
?_r=0. France and Germany, which grow no GM crops, have increased their crop yields at the same rate 
as the United States over past decades. Id. Those countries, however, have far lower rates of both 
pesticide and herbicide use. Id.  
99.  Elizabeth Grossman, What Do We Really Know About Roundup Weed Killer?, NAT’L 
GEOGRAPHIC (Apr. 23, 2015), https://perma.cc/6WRD-SN3H. 
100.  Id.  
101.  Id.  
102.  Id. 
103.  Glyphosate, EPA, https://perma.cc/8PC2-QXXP.  
104.  WORLD HEALTH ORG.: INT’L AGENCY FOR RESEARCH ON CANCER, IARC MONOGRAPHS 
VOLUME 112: EVALUATION OF FIVE ORGANOPHOSPHATE INSECTICIDES AND HERBICIDES (Mar. 2015), 
https://perma.cc/EWK9-6GLX. In 1985, the EPA classified glyphosate as “possibly” carcinogenic, but 
in 1991 re-evaluated its study and changed the classification. Id. The International Agency for Research 
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Studies also indicate that the non-active ingredients in Roundup may be 
even more hazardous than glyphosate itself.105 Nearly all of the corn and 
soybeans seeds sold by Monsanto are “Roundup Ready”—genetically 
engineered to withstand the herbicide while the weeds shrivel under its 
lethal spray.106 GMO labeling laws would require the manufacturer of food 
products made with Roundup Ready corn and soybeans to disclose that the 
food contains GM ingredients, but not that the corn was doused in herbicide. 
Once rarely found in food, glysophate residue is now present in Roundup 
Ready crops because of its heightened use.107  
Labeling requirements give consumers discretion in choosing whom 
they purchase their products from and allow them to make a statement with 
their purchases. Even if they don’t believe that GMOs are harmful, they may 
still not want to lend their support to companies like Monsanto for other, 
perhaps more justifiable reasons, like the proven dangers associated with 
pesticide usage. 108 It is easy to boycott a company by not buying their 
products, but much more challenging, even impossible, to avoid 
contributing to such a pervasive conglomerate. 
Therefore, it is difficult to determine what type of labeling scheme would 
be satisfactory to the majority of Americans who believe that they have a 
right to know whether their food contains genetically engineered 
ingredients.109 Staunch proponents of GMO labeling are disappointed with 
the passage of the federal law which they believe does not impose strict 
enough requirements on food manufacturers. 110  However, in theory, 
voluntary requirements that go beyond the nonbinding guidance from the 
                                                
on Cancer examined the results from the original EPA study in conjunction with more recent tests to 
determine that glyphosate should be correctly classified as a probably carcinogen. Id.  
105.  Crystal Gammon, Weed-Whacking Herbicide Proves Deadly to Human Cells, SCI. AM. 
(June 23, 2009), https://perma.cc/57K8-X6V8. “One specific inert ingredient, polyethoxylated 
tallowamine, or POEA, was more deadly to human embryonic, placental and umbilical cord cells than 
the herbicide itself – a finding the researchers call ‘astonishing.’” Id.  
106.  Saletan, supra note 95.  
107.  Id.  
108.  See e.g., Philip L. Weinstein, Legal Implications of the Natural Migration of Patented 
Transgenic Plants, 5 BIOTECHNOLOGY & PHARMACEUTICAL L. REV. 137 (2011–2012).  
Monsanto protects its intellectual property rights in the transgenic plant seeds by using patent 
protection and contractual license agreements . . . . Monsanto also requires farmers to sign a 
licensing agreement, which among other restrictions, bars the farmer from replanting ‘saved 
seeds,’ seeds recovered from the previous year's crop, from season to season.  
Id. at 138. Seeds travel naturally, and GM seeds look no different than non-GMO seeds of the same plant 
variety, making it easy for farmers to inadvertently grow Monsanto-patented seeds and then face 
litigation. Id.; see also Monsanto Guilty in ‘False Ad’ Row, BBC NEWS (Oct. 15, 2009, 2:13 PM), 
https://perma.cc/636J-XES4.  
109.  Allison Kopicki, Strong Support for Labeling Modified Foods, N.Y. TIMES (July 27, 2013), 
https://nyti.ms/177pk7I. “93 percent of respondents [said] that foods containing such ingredients should 
be identified.” Id. However, only three-quarters of the respondents were actually concerned about the 
presence of GMOs in their food. Id. 
110.  Halloran, supra note 73.  
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FDA will lead to the result that labeling supporters desire.111 Many activist 
groups adamantly oppose the presence of any GMOs, and seek an outright 
ban on their usage. Greenpeace, for example, declares that “GMOs should 
not be released into the environment since there is not an adequate scientific 
understanding of their impact on the environment and human health” and 
opposes “all patents on plants, animals and humans, as well as patents on 
their genes.” 112   This aspiration—that GMOs will be completely 
eliminated—will likely  never transpire, given the current prevalence of 
GMOs and the nature of the global economy.113     
D. Legal Challenges to GMO Labeling Laws 
Labeling requirements on products for purchase are an issue of 
commercial disclosure, a subcategory of protected speech under the First 
Amendment.114 Laws that impose limitations on commercial speech are 
subject to intermediate scrutiny. 115  However, appellate decisions 
concerning the constitutionality of labeling laws indicate that surviving 
intermediate scrutiny may be challenging even for the recently-passed Safe 
Act.    
In the Vermont District Court case which ultimately denied a preliminary 
injunction against the state’s labeling law,116 the Court applied a reasonable 
relationship test, relying on Zauderer v. Office of Disciplinary Counsel of 
the Supreme Court of Ohio.117 In Zauderer, the Supreme Court held that 
“disclosure requirements [must be] reasonably related to the State's interest 
in preventing deception of consumers.”118 In order for Zauderer to apply 
rather than a higher level of scrutiny, the questioned speech must be 
commercial in nature, purely factual rather than controversial, and 
supported by an interest in something more than merely satisfying the 
                                                
111.  See Donna M. Byrne, Cloned Meat, Voluntary Food Labeling, and Organic Oreos, 8 PIERCE 
L. REV. 31, 49 (2009) (“[I]n a sense, there is no truly voluntary labeling.”).  
112.  Genetic Engineering, GREENPEACE INTL., https://perma.cc/63M7-MBTF (last visited Aug. 
23, 2017).  
113.    In the European Union, only GM crops that have passed an assessment by the European Food 
Safety Authority and undergone a regulatory process by the European Commission may be cultivated. 
Margaret Rosso Grossman, European Community Legislation for Traceability and Labeling of 
Genetically Modified Crops, Food, and Feed  in LABELING GENETICALLY MODIFIED FOOD 32, supra 
note 25. Individual European countries may impose prohibitions on the cultivation of GM products. 
Alexandra Sifferlin, Over Half of E.U. Countries are Opting Out of GMOs, TIME (Oct. 3, 2015), 
https://perma.cc/7WJC-GYS3.  
114.  See Cent. Hudson Gas & Elec. Corp. v. Pub. Serv. Comm’n of N.Y., 447 U.S. 557 (1980).  
115.  Id. If a commercial communication “is neither misleading nor related to unlawful activity,” 
then the government must prove that it has a “substantial interest” in regulatory power, and the regulation 
must be proportionate and “designed carefully” to achieve the government interest. Id. at 564.  
116.  Grocery Mfrs. Ass’n v. Sorrell, 102 F. Supp. 3d 583 (D. Vt. 2015).  
117.  471 U.S. 626 (1985).  
118.  Id. at 651.  
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curiosity of consumers, or in other words, the consumers’ right to know.119 
The court found that “some of the State’s interests arguably border on the 
appeasement of consumer curiosity,” but looked only for a reasonable 
relationship for purposes of denying the preliminary injunction.120 It did not 
rule out the possibility, however, that the law would ultimately have to 
withstand intermediate scrutiny.121  
An earlier Vermont labeling law did not survive a motion for preliminary 
injunction.122 In 1994, the state enacted a statute requiring dairy producers 
to include disclosures on their product labels if the cows used to make their 
products had been treated with rBST, a synthetic growth hormone.123 The 
Second Circuit held that the defendants would likely suffer irreparable harm 
because of the statute, which trampled on their “constitutional right not to 
speak.”124 When evaluating the likelihood of the defendants’ success on the 
merits, the court concluded that Vermont did not have a substantial interest 
in the adoption of the statute because the law was justified on the basis of 
“the public’s right to know.”125 The right to know, according to the court, is 
“insufficient to justify compromising protected constitutional rights.”126  
The New York City Board of Health adopted a regulation in 2006 
requiring certain restaurants to publish the calorie content of their products 
so as to be conspicuously displayed to customers before they order.127 The 
New York State Restaurant Association (NYSRA) challenged the 
regulation, seeking a preliminary injunction on the ground that, among 
others, the disclosure requirement was a form of compelled speech that 
violated restaurants’ First Amendment rights.128 NYSRA was fighting for 
heightened scrutiny, but the Second Circuit applied only rational basis 
review.129 In deciding whether a reasonable relationship existed between the 
                                                
119.  Id.  
120.  Sorrell, 102 F. Supp. 3d at 631.  
121.  Id. at 633.  
122.  Intl. Dairy Foods Ass’n, 92 F.3d 67 (2d Cir. 1996).  
123.  Id. at 69.  
124.  Id. at 71. 
125.  Id. at 73. 
126.  Id.  
127.  N.Y. State Rest. Ass’n v. N.Y. City Bd. of Health, 556 F.3d 114, 120–21 (2d Cir. 2009).  
128.  Id.  
129.  Id. at 132.  
Commercial disclosure requirements are treated differently from restrictions on commercial 
speech because mandated disclosure of accurate, factual, commercial information does not 
offend the core First Amendment values of promoting efficient exchange of information or 
protecting individual liberty interests. Such disclosure furthers, rather than hinders, the First 
Amendment goal of the discovery of truth and contributes to the efficiency of the ‘marketplace 
of ideas.’ Protection of the robust and free flow of accurate information is the principal First 
Amendment justification for protecting commercial speech, and requiring disclosure of truthful 
information promotes that goal. In such a case, then, less exacting scrutiny is required than 
where truthful, nonmisleading commercial speech is restricted. 
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requirement and purpose of the New York regulation, the court detailed the 
alarming prevalence of obesity and obesity-related diseases in the City and 
examined the City’s statistical evidence linking these health problems to 
consumers eating unhealthy food in restaurants, unwittingly consuming an 
excessive amount of calories.130 Given the validity, quality, and wealth of 
the evidence, the City’s regulation easily stood up to this low level of 
scrutiny.131  
In 2014, the D.C. Circuit ruled on the constitutionality of a statute 
promulgated by the USDA which required certain meat products to be 
labeled with their countries of origin.132 The Court ultimately found that the 
government had a substantial interest in providing consumers with country-
of-origin details in order to protect American industry,133 but rejected the 
argument that the labeling requirement was justified by the government’s 
interest in “providing consumers with information.” 134  Such broad 
contentions would “be true of any and all disclosure requirements” and 
would effectively preclude the success of any legal challenges.135  
These cases suggest that the consumers’ “right to know” may be 
considered a legitimate justification for disclosure requirements, but the 
imparted knowledge must impact a consumer in such a way that will further 
the government interest. If restaurant-goers can clearly see that a “taco salad 
contains 840 calories,”136 they will hopefully pick less caloric options. If 
Americans overeat at restaurants less frequently, they will lose weight and 
reduce the country’s obesity rate. In the same vein, if people perusing the 
supermarket can readily identify which items were produced in the United 
States, they may choose a domestic product rather than an imported one. 
Purchasing American products will help American workers and companies 
who are competing with the global market.  
When the government seeks to justify a restriction on commercial 
speech, its justification “is not satisfied by mere speculation or conjecture; 
rather, a governmental body seeking to sustain a restriction on commercial 
speech must demonstrate that the harms it recites are real and that its 
                                                
Id. (quoting Nat’l Elec. Mfrs. v. Sorrell, 272 F.3d 104, 113–14 (2d. Cir. 2001)).  
130.  Id. at 120.  
131.  Id. at 134–37.  
132.  Am. Meat Inst. v. U.S. Dep’t of Agric., 760 F.3d 18 (D.C. Cir. 2014).  
133.  The court addressed the “[g]overnment’s historically rooted interest in supporting American 
manufacturers, farmers, and ranchers as they compete with foreign manufacturers, farmers, and 
ranchers.” Id. at 32. Providing country-of-origin information on meat packaging would give consumers 
the opportunity to easily choose American products over products imported from other countries. Id. 
134.  Id. at 31.  
135.  Id.  
136.  N.Y. State Rest. Ass’n, 556 F.3d at 121.  
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restriction will in fact alleviate them to a material degree.”137 This is the 
primary legal problem faced by labeling-advocates in the case of GMOs. 
Even the studies claiming that GMOs are malignant are not in accord as to 
the purported destructive effects of GMOs,138 giving no legally viable basis 
to arguments based in the effect on health.   
III. LIKELY EFFECTS OF NEW FEDERAL LEGISLATION 
Even if the Safe Act is eventually repealed or struck down, it will be 
nearly impossible for subsequent state labeling laws to avoid a similar 
fate.139 First Amendment jurisprudence creates potentially insurmountable 
obstacles against GMO labeling requirements that are put in place to address 
the “risks” of GMOs, as well as ones which intend to protect the consumers’ 
right to know.140  
 Despite the attention and outcry focused on labeling schemes, the free 
market appears to be working effectively, giving anti-GMO proponents 
power over big agri-business despite legislative failures.141 The negativity 
surrounding GMOs has caused many consumers to actively seek non-GMO 
products, giving that segment of the market a significant profit upsurge.142 
Farmers are also switching.143 GM seeds may cost nearly twice as much as 
seeds without GM traits.144 Although some farmers claim to have seen the 
increased yields promised by biotech companies, their profits are falling 
along with the price of their corn and soybeans.145 People are paying a 
premium for non-GMO items, and therefore farmers have the potential to 
earn far more by cultivating crops free from genetic modification, even if 
they consequently spend more on farm chemicals.146 Some of the biggest 
players in the food industry, including General Mills and Post, have begun 
                                                
137.  Grocery Mfrs. Ass’n v. Sorrell, 102 F. Supp. 3d 583, 641 (D. Vt. 2015) (quoting Fla. Bar v. 
Went For It, Inc., 515 U.S. 618 (1995)).  
138.  See Health Risks, INST. FOR RESPONSIBLE TECH., https://perma.cc/6FZ7-TF9V (last visited 
Sept. 9, 2017) (claiming that GMO consumption leads to infertility and accelerated aging); Arjun Walia, 
New Study Links GMOs to Cancer, Liver/Kidney Damage & Severe Hormonal Disruption, COLLECTIVE 
EVOLUTION (July 15, 2014), https://perma.cc/LD4V-UE7C (claiming that GMO consumption causes 
cancer as well as damage to hormones and organs).  
139.  See discussion supra Part II.D.  
140.  Id.  
141.  See discussion supra Part II.C.  
142.  Jacob Bunge, Fields of Gold: GMO-Free Crops Prove Lucrative for Farmers, WALL ST. J. 
(Feb. 2, 2015, 3:41 PM), https://www.wsj.com/articles/fields-of-gold-gmo-free-crops-prove-lucrative-
for-farmers-1422909700.  
143.  Hakim, supra note 98.  
144.  Id. A 50,000-seed bag of Roundup Ready corn seeds costs about 153 dollars, while corn 
seeds without genetic engineering cost about eighty-five dollars. Id. 
145.  Bunge, supra note 142. Corn prices have fallen fifty percent over the last two years; soybean 
prices have fallen thirty-five percent. Id.  
146.  Id.  
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to manufacture GMO-free products, a significant action considering the 
volume of genetically engineered corn and soy purchased by such 
companies.147 
Monsanto’s Executive Vice President and Chief Technology Officer had 
a cutting reply to reporters claiming that the biotech industry is failing to 
live up to its promises regarding genetic engineering: “[F]armers are smart 
business people who won’t waste time or money on tools that don’t deliver 
results.”148 He ended his rebuke with the assertion that “the voice of the 
farmer should be represented.”149 His statements ring true, though perhaps 
not in his favor.  
The Safe Act is a weak mandatory labeling scheme, which has been 
derisively equated to a voluntary one.150 Yet even if the potency of its 
provisions render it essentially voluntary, it is likely to have an effect similar 
to that of a strong labeling scheme due to the driving power of the market.151 
If certain products are labeled GMO-free, consumers will, based on polls 
evidencing consumer preference for food made without GMOs, choose 
those products over their non-labeled, GMO-free counterparts. 152 
Companies who don’t use GM ingredients will be encouraged to label their 
products as GMO-free, thereby incurring the costs that come along with it 
and transferring the cost to the consumer.153 When some food items contain 
labels advertising themselves as made without GM ingredients, comparable 
items that lack such a label will be viewed as inferior by a discerning 
consumer, who will probably be willing to pay a premium for the product 
that he deems safer or of better quality.154 Although the FDA prohibits 
labels that suggest that GMO-free foods are healthier, safer, or in any way 
superior to foods containing GM ingredients, it cannot control consumer 
bias. 155  Even if the product labeled as made without GM ingredients 
                                                
147.  Id.  
148.  Robert T. Fraley, Letter to the Editor, Monsanto, on Genetically Modified Crops, N.Y, 
TIMES (Nov. 11, 2016), https://www.nytimes.com/2016/11/12/opinion/monsanto-on-genetically-modi 
fied-crops.html.  
149.  Id.  
150.  See supra note 44 and accompanying text.  
151.  See generally Byrne, supra note 111.  
152.  Id. at 49. 
153.  Id.  
154.  Id. at 48–49. The author explains that voluntary labeling schemes are “de facto” mandatory, 
because once one product sports a claim that it possesses a positive characteristic (in this case, no GM 
ingredients), it will be viewed as better than the same product that cannot make the same claim. Id. “If 
wild fish is good, then there must be something bad about farm-raised fish. If ‘no GMOs’ is worth 
mentioning, then GMOs must be bad . . . . Once some producers use a label, other products bear a de 
facto label in the opposite direction.” Id. at 49.  
155.  See Guidance for Industry, supra note 32; see also Thomas O. McGarity, Frankenfood Free: 
Consumer Sovereignty, Federal Regulation, and Industry Control in Marketing and Choosing Food in 
the United States, in LABELING GENETICALLY MODIFIED FOOD 142, supra note 25, at 142. The FDA 
allowed milk producers to state on their bottles that their milk came from cows that were not treated 
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disclaims that it is no better for health than a similar product made with GM 
ingredients, the public attitude toward GMOs may make such a statement 
irrelevant to consumers.156 Though the impending mandatory regulatory 
scheme will allow producers to hide information behind smart-phone 
accessible bar codes or directions to their websites, they will still not be 
permitted to tout their products as made without GM ingredients, while 
other products will.157 As discussed in the previous section, labeling efforts 
even in the absence of a comprehensive regulatory scheme have begun to 
affect the largest producers and distributors of GMOs. Consumers who care 
deeply about the absence of genetically engineered ingredients in their food 
will not be deceived by the new scheme, but even less-discerning consumers 
may choose more expensive products (which sport obvious assurances of 
being free from GMOs), rather than ones with more enigmatic labels that 
effectively equate to no GMO label at all.158  
Although all products covered by the Safe Act will still be subject to the 
limitations imposed by the FDA, concerns remain that products containing 
unacceptable levels of GM ingredients will be able to permissibly bear a 
“GMO-free” label under the Safe Act.159 This potential risk is reduced, 
however, by the presence of independent organizations who provide 
verification that products comply with their own standards, which are 
unrelated to any standards the government may impose.160 The conspicuous 
label of perhaps the most prominent verification organization, the Non-
                                                
with the hormone rBST, but required an additional disclaimer stating that there was no evidence showing 
that milk derived from cows treated with the hormone was any different than the milk from cows without 
it. Id.  
156.  Peters & Lambert, supra note 82, at 163. In the case of rBST, even milk producers who did 
not treat their cows with the hormone chose not to provide labels stating as such, in light of the FDA 
requirements that they must essentially also disclaim that this made their product no better than another 
which contained rBST. Id. Therefore, most consumers could not learn simply from looking at the cartons 
which milk came from rBST treated cows and which did not. Id. However, evidence shows that even 
though the public is constantly reassured that GMOs are not harmful to human health, most people are 
still wary. It is unlikely that a label disclaiming any beneficial health effects of not eating GMOs would 
change their minds.  
157.  Act of July 29, 2016, Pub. L. No. 114-216, 130 Stat. 834, 834–39 (2016). 
158.  Byrne, supra note 111, at 64. Consumers who are very knowledgeable about the content of 
their food will not be misled by labels. Id. Theoretically, consumers who do not care strongly about 
GMOs would choose the foods that are not labeled as GMO free; however, this may not be the case. Id. 
at 60. Bryne explains: 
Sometimes people make choices that increase their welfare based on misunderstandings or 
based on false assumptions. If choices that increase welfare are desirable, then they are the 
‘right’ choices. Reasoning based on false information or misapprehension is to be avoided, and 
thus represents a ‘wrong’ reason. In other words, sometimes people make the right choices for 
the wrong reasons. 
Id.  
159.  Safe Act, supra note 157.  
160.  See, e.g., About, NON-GMO PROJECT, https://www.nongmoproject.org/about/ (last visited 
Aug. 23, 2017). 
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GMO Project, can be found on close to 40,000 products, from baby formula 
to wine, condiments to dog treats, vitamins to make-up.161 The non-profit 
applies different levels of inspection depending on the likelihood that a 
product contains GM ingredients; products containing ingredients that are 
commonly GM are subject to more extensive testing.162 Products will retain 
their Non-GMO certification so long as the “GMO contamination” level in 
a product does not rise above certain thresholds.163 Because the federal 
labeling scheme cannot extinguish verification efforts by independent 
organizations, they provide another layer of assurance that a product is 
GMO-free, and therefore another purchasing cue for consumers who are 
attempting to avoid products containing GMOs. An item with a seal of 
approval from the Non-GMO Project may seem more appealing to 
consumers than items that are self-proclaimed as GMO-free.164 
CONCLUSION 
Even with the security of an impending federal regulatory scheme 
imposing mandatory labeling requirements on foods containing GMOs, the 
future of GMO disclosure laws is still uncertain. Although there are many 
potentially legitimate reasons for consumers to want to avoid eating GM 
foods, labeling laws that are derived solely based on the nebulous notion of 
a consumers’ right to know rest on shaky ground.165 Once implemented, the 
Safe Act may not serve as the robust and comprehensive mandatory labeling 
bill that pro-consumer advocates had hoped for, but even with its 
shortcomings it will help to effectuate the anti-GMO agenda.166 Americans 
who care about their food’s contents will not be fooled by dubious labels, 
and even those who do not care will be subliminally coaxed into buying 
non-GMO products.167 GMOs will almost certainly never disappear from 
farms or from products in grocery stores, but the market’s response to 
federal legislation will diminish their presence and create a better-informed 
consumer.168  
                                                
161.  Id.  
162.  NON-GMO PROJECT, NON-GMO PROJECT STANDARD (2016), https://perma.cc/L4LX-
R5S7. 
163.  Id. at 7, 10. For example, the level of GMOs cannot rise above .9 percent for human food 
and products ingested or used directly on the skin, and not above five percent for animal feed and 
supplements. Id. at 11.  
164.  See Byrne, supra note 111 and accompanying text. 
165.  See discussion supra Part II.D.  
166.  See discussion supra Part III.  
167.  See discussion supra Part III.  
168.  See discussion supra Part III.  
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